“showed a trend”

Improvements in hope over time showed a trend ( p = 0.06).

In contrast, subjects receiving treatment with Cat‐PAD showed a trend toward downregulation of CRTh2 ( P = 0.06) which was significant when comparing the change in MFI between subjects in the placebo vs active group ( P = 0.047) (Figure 5 ). 4.

In the standard dosing group, the median weight did not significantly change at 3 months (weight 92 kg; IQR 79–107 kg, p = 0.65) but showed a trend toward lower body weight at 6 months (weight 90 kg; IQR 80–112 kg, p = 0.06).

Additionally, baseline TOMM20 expression showed a trend towards a positive correlation with increasing tumour grade [Spearman’s correlation r = 0.33 (95% CI −0.2, 0.63), p = 0.06].

Unemployment showed a trend toward an association with a delay to presentation on multivariable analysis (RR, 1.31; 95% CI: 0.98, 1.76; p = 0.06) (Table II).

The difference in the fraction of breast cancer patients with an elevated bFGF serum level (58%) and colorectal cancer patients with an elevated bFGF serum level (33%) showed a trend towards significance (chi-squared test P = 0.06).

Notably, even patients who did not undergo transplantation showed a trend toward improved 4-year OS (21% vs. 16%, P = 0.06) ( 4 ).

The postoperative echocardiography showed a trend towards an improvement in the LVEF in Group B ( p = 0.06) and a significant improvement in Group A ( p = 0.002).

The simple main effect of test time showed that the cognitive training group significantly improved on executive control, F (1,66) = 28.57, p < 0.001, η p 2 = 0.30, the active control group showed a trend of improvement, F (1,66) = 3.61, p = 0.06, η p 2 = 0.05, and the waitlist group did not show any improvement ( p = 0.84).

Metabolic rate in the Latest Time-torque bin showed a trend towards being lower than the Spring-like condition (p = 0.06, paired t-test).

Bacterial flow cytometry analysis of AMD fecal samples ( Fig 4 A) showed a trend toward increased IgA-coated bacteria with higher AMD GRS ( P = 0.06; Spearman’s r = 0.2) ( Fig 4 B).

Notably, in the dorsal DG, NOV increased c‐Fos expression in the superior blade in comparison to the NSD group ( p < 0.01, Figure 3E ) while it showed a trend toward a decrease ( p = 0.06, Figure 3E ) in the inferior blade.

CRT significantly reduced local progression rates (32% versus 46%, p = 0.030) and showed a trend towards better median PFS (9.9 versus 8.4 months, p = 0.060) and longer median time without retreatment (6.1 versus 3.7 months, p = 0.020).

The VTE group showed a trend towards more frequent open reduction and internal fixation (73.2% vs. 58.2%, p = 0.06).

Post-BD FEV 1 /FVC likewise showed a trend towards improvement (p=0.06) ( supplementary figure S7 ).

Thalamic volume at the three months MRI showed a trend towards correlation, while total brain volume did not show a correlation with SWI during follow-up (rho −0.42; p = 0.06 and rho −0.23; p = 0.32, n = 21).

Regarding the integrated EMG (iEMG) activity in each muscle, two-way ANOVA with repeated measures showed no effect of the ‘condition’ ( F (1,14) = 3.0, P = 0.09, η 2 = 0.002; TB muscle, EF: 46 ± 4% of maximum voluntary contraction [MVC], IF: 52 ± 6%MVC; TA muscle, EF: 11 ± 2%MVC, IF: 9 ± 1%MVC; SOL muscle, EF: 27 ± 6%MVC, IF: 25 ± 5%MVC), but the AD muscle (EF, 55 ± 8%MVC; IF, 59 ± 9%MVC) showed a trend of less activity in the EF condition than in the IF condition (post hoc, P = 0.06).

In addition, participants in the OO group showed a trend ( P = 0.06) toward an increase in plasma HDL-C levels compared to the CON group after 3 months (Table 5 ).

High-level microsatellite instability CRCs showed a trend towards a higher infiltration with FOXP3-positive cells in the tumour stroma (median: 181.5 cells per 0.25 mm 2 in MSI-H vs 137.1 cells per 0.25 mm 2 in MSS, P =0.06) and a significantly higher intraepithelial infiltration with FOXP3-positive Treg cells (median: 8.5 cells per 0.25 mm 2 in MSI-H vs 3.1 cells per 0.25 mm 2 in MSS, P <0.001).

The main effect of SWITCH showed a trend, F (1,19) = 4.07, p = 0.06, and interacted with prevGO, F (1,19) = 4.83, p = 0.03.

Following non-targeted therapy, no significant changes in Shannon diversity, bacterial community structure, and relative abundance of genera and staphylococcal species were observed ( Figures S5–S7 ), although the community structure of nonlesional skin showed a trend for significant change ( p = 0.06) ( Table 2 ).

Serum IL-6 levels showed a trend toward reduction after treatment (pre-treatment 1.75 [1.02–2.23] pg/mL vs post-treatment 0.92 [0.26–2.36] pg/mL; P = 0.06 ).

A 2 × 2 × 2 mixed ANOVA (Experiment × Emotion × Order) with experiment added as a between participants factor showed a trend of a main effect of experiment ( F [1, 51] = 3.58, p = .06, η P 2 = 0.07; all other p ’s > 0.43) with a greater decrease in dependency in Experiment 3 (i.e., following a 24-hour delay) suggesting that a 24 hour delay might reduce dependency.

Secondary end points Acquired points on the ASIA motor score at 6 and 12 months after drug administration showed a trend towards improvement in the G-CSF group compared to the control group (6 months: G-CSF group, 40.5 ± 22.0, control group, 35.6 ± 22.6, P = 0.06; 12 months: G-CSF group, 41.8 ± 22.9, control group, 37.2 ± 20.9, P = 0.07; Fig. 3A ) in PPS analysis with last observation carried forward supplementation.

The MS-ECTresp showed a trend towards association with ECTresp (p < 0.06) in the German cohort for the continuous model (Supplementary Table 22 ).